METAVIA INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- METAVIA INC. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $383.00K.
- METAVIA INC. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $314.00K.
- METAVIA INC. stock issued during period, value, new issues for the quarter ending 2021-03-31 was $10.00M.
- METAVIA INC. stock issued during period, value, new issues for the quarter ending 2020-06-30 was $7.50M.
- METAVIA INC. stock issued during period, value, new issues for fiscal 2025 was $861.00K.
- METAVIA INC. stock issued during period, value, new issues for fiscal 2020 was $7.50M, a 67.94% increase from fiscal 2019.
- METAVIA INC. stock issued during period, value, new issues for fiscal 2019 was $4.47M, a 82.24% decline from fiscal 2018.
- METAVIA INC. stock issued during period, value, new issues for fiscal 2018 was $25.15M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $383.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $314.00K 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $861.00K 10-K · filed 2026-03-26 | |
| 2021-03-31 | $10.00M 10-Q · filed 2021-11-15 | |
| 2020-12-31 | $7.50M 10-K · filed 2022-03-31 | |
| 2020-06-30 | $7.50M 10-Q · filed 2021-11-15 | |
| 2019-12-31 | $4.47M 10-K · filed 2021-04-15 | |
| 2018-12-31 | $25.15M 10-K · filed 2019-03-18 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | |
| 2018-03-31 | $25.15M 10-Q · filed 2019-11-08 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $30.28M 10-K · filed 2019-03-18 |
| 2015-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | $911.00K 10-K · filed 2018-03-20 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |